Abstract
The increasing number of positive cases of SARS-CoV-2 worldwide led to a catastrophic breakdown in the global economy and unprecedented social disruptions. These measures have significantly impacted the world’s economy and in many cases has led to the loss of livelihood. Mathematical modeling of pandemics is of critical importance to understand the unfolding of transmission events and to formulate appropriate control measures. In this article, we introduce a physics based approach for forecasting epidemics such as COVID-19. The proposed physics-based mathematical model stems from the fundamental principles of fluid dynamics, and can be utilized to make projections of the number of infected people at any scale. Our model takes into account the diffusive transmission of the virus, the growth of virus inside the human body and the response of the natural immune system of individuals. We demonstrate that the health of individuals plays a critical role in controlling the evolution of the epidemic. In places where the individuals exhibit a strong immune system, the development of pandemic is limited despite high diffusivity of the virus. Overall, the proposed mathematical model can be beneficial for predicting and designing potential strategies to mitigate the spread and impact of pandemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Harris Sajjad Rabbani would like to acknowledge Dr. Nida Jaleel for the insightful discuss on the topic.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data presented in this manuscript will be available freely via sending a request to the corresponding author.
